Tech Company Financing Transactions
Orchid Funding Round
Prometheus Capital, Conviction Capital and Day One Ventures participated in a $12 million venture round for Orchid. The financing round was announced by the company on 12/5/2023.
Transaction Overview
Company Name
Announced On
12/5/2023
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The aim is to detect any serious diseases, ranging from neurodevelopment disorders to cancers, at an early stage so prospective parents can choose the healthiest embryo possible during their IVF procedure.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Undisclosed
San Francisco, CA 94131
USA
San Francisco, CA 94131
USA
Phone
Undisclosed
Website
Email Address
Overview
Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid's preconception system analyzes both partners' genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer's disease, breast cancer, and diabetes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Noor Siddiqui
Browse more venture capital transactions:
Prev: 12/5/2023: Carbon Maps venture capital transaction
Next: 12/5/2023: Klarytee venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs